Inventor · disambiguated record
Lifeng Wan
Also filed as: WAN LIFENG
14 granted patents·9 pending applications·49 citations·filing 2010–2024
91Inventor score
Top patents by PatentIndex Score
23 records- 0192US11098051B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Aug 24, 2021·5 cites·19 claims
- 0292US10160764B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Dec 25, 2018·11 cites·29 claims
- 0391US11453677B2Tricyclic compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2020·Granted Sep 27, 2022·2 cites·14 claims
- 0489US10709712B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2019·Granted Jul 14, 2020·3 cites·7 claims
- 0584US10245267B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2017·Granted Apr 2, 2019·3 cites·4 claims
- 0684US9694016B2Biaryl amide compounds as kinase inhibitorsNOVARTIS AG·Filed 2014·Granted Jul 4, 2017·5 cites·8 claims
- 0784US2025011334A1Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0882US11629149B210-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenzaNOVARTIS AG·Filed 2019·Granted Apr 18, 2023·3 cites·4 claims
- 0982US10167279B2Compounds and compositions as RAF kinase inhibitorsNOVARTIS AG·Filed 2015·Granted Jan 1, 2019·3 cites·17 claims
- 1081US10858366B2Tricyclic compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2017·Granted Dec 8, 2020·3 cites·20 claims
- 1181US8415381B2Heteroaryl compounds and their usesBARSANTI PAUL A·Filed 2010·Granted Apr 9, 2013·7 cites·12 claims
- 1279US8778951B2Heteroaryl compounds and their usesNOVARTIS AG·Filed 2013·Granted Jul 15, 2014·4 cites·8 claims
- 1377US2025034156A110-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1 ',2':4,5]pyrazino[1,2-B]pyridazine-3,5-dione Derivatives and Related Compounds as Inhibitors of the Orthomyxovirus Replication for Treating InfluenzaNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1474US12071441B210-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenzaNOVARTIS AG·Filed 2023·Granted Aug 27, 2024·0 cites·4 claims
- 1573US11912715B2Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infectionsNOVARTIS AG·Filed 2021·Granted Feb 27, 2024·0 cites·22 claims
- 1654US2014288076A1Heteroaryl compounds and their usesBARSANTI PAUL A·Filed 2014·Application pending·0 cites
- 1749US2014228363A1Tetrasubstituted cyclohexyl compounds as kinase inhibitorsBURGER MATTHEW·Filed 2014·Application pending·0 cites
- 1844US2012225061A1Tetrasubstituted cyclohexyl compounds as kinase inhibitorsBURGER MATTHEW·Filed 2012·Application pending·0 cites
- 1939US2013303507A1Substituted hetero-biaryl compounds and their usesANTONIOS-MCCREA WILLIAM R·Filed 2012·Application pending·0 cites
- 2038US2013324530A13-(aminoaryl)-pyridine compoundsANTONIOS-MCCREA WILLIAM R·Filed 2011·Application pending·0 cites
- 2137US2012225062A1Novel kinase inhibitorsBURGER MATTHEW·Filed 2012·Application pending·0 cites
- 2237US2013109682A1Cyclic ether compounds useful as kinase inhibitorsBURGER MATTHEW·Filed 2011·Application pending·0 cites
- 2335US10392404B2Compounds and compositions as kinase inhibitorsNOVARTIS AG·Filed 2015·Granted Aug 27, 2019·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Lifeng Wan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →